ALBURX SOLUTION FOR INFUSION 5%

INFUSION, SOLUTION

**Posology/Method of administration** The concentration of the albumin solution used, the dosage and the infusion rate should be adjusted to the patient’s individual requirements. _**Posology**_ The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid or protein losses. Measurements of the circulating blood volume, and not just of the plasma albumin level, should be used to determine the dose required. Human albumin should be administered under careful haemodynamic monitoring; the parameters include: - arterial blood pressure and heart rate, - central venous pressure, - pulmonary artery wedge pressure, - urine output, - electrolytes, - haematocrit/haemoglobin. Paediatric population The posology in children and adolescents (0 – 18 years) should be adjusted to the patient’s individual requirements. **_Method of administration_** AlbuRx™ 5 is administered intravenously. The infusion rate should be adjusted according to the individual circumstances and the indication, but should normally not exceed 5 ml/min. In plasma exchange the infusion rate should be adjusted to the rate of removal.